Renovia racks up $42.3 mln
Boston-based Renovia, a provider of digital therapeutic and diagnostic devices that help women with pelvic floor dysfunction, has raised $42.3 million in funding, which included $32.3 million in Series B equity and $10 million in venture debt. Perceptive Advisors and Ascension Ventures led the Series B round with participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF Ventures and Western Technology Investment. And, WTI also provided the venture debt. BayCross Capital Group LLC advised Renovia on the transaction.
24 September 2018•1 min read
